Sharps Technology Inc., (STSS): Price and Financial Metrics
STSS Price/Volume Stats
| Current price | $1.00 | 52-week high | $2.04 |
| Prev. close | $0.99 | 52-week low | $0.76 |
| Day low | $0.95 | Volume | 255,000 |
| Day high | $1.02 | Avg. volume | 662,276 |
| 50-day MA | $1.06 | Dividend yield | N/A |
| 200-day MA | $1.22 | Market Cap | 11.64M |
STSS Stock Price Chart Interactive Chart >
Sharps Technology Inc., (STSS) Company Bio
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Latest STSS News From Around the Web
Below are the latest news stories about SHARPS TECHNOLOGY INC that investors may wish to consider to help them evaluate STSS as an investment opportunity.
Sharps Technology, Inc. and BullFrog AI Holdings, Inc. Interviews to Air on Bloomberg TV on the RedChip Money Report(R)RedChip Companies will air new interviews with Sharps Technology, Inc. (NASDAQ:STSS; STSSW) and BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) on The RedChip Money Report® on Bloomberg TV, this Saturday, May 20, at 7 p.m. Eastern Time (ET). |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayIt's time for another dive into the biggest pre-market stock movers as we see what shares are on rising and falling on Tuesday! |
We Might See A Profit From Sharps Technology, Inc. (NASDAQ:STSS) SoonWe feel now is a pretty good time to analyse Sharps Technology, Inc.'s ( NASDAQ:STSS ) business as it appears the... |
BullFrog AI and Sharps Technology Interviews to Air on Bloomberg U.S. on the RedChip Money Report(R)RedChip Companies will air new interviews with BullFrog AI (NASDAQ:BFRG) and Sharps Technology (NASDAQ:STSS) on The RedChip Money Report® on Bloomberg TV, this Saturday, April 8, at 7 p.m. Eastern Time (ET). |
Sharps Technology Issues Update Letter to Shareholders from CEO Robert HayesCommercial revenue from specialty safety syringe systems is advancing Company to launch its vial draw syringe systems in Q2 2023Launch of high-value, next-generation polymer-based products expected in Q3 2023 NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, issues a shareholder update from Robert Hayes, the Company's Chief Exe |
STSS Price Returns
| 1-mo | 26.58% |
| 3-mo | -22.48% |
| 6-mo | -21.88% |
| 1-year | -5.66% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -17.36% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...